Treatment · International

JAMA Psychiatry: once-weekly semaglutide in adults with alcohol use disorder

A randomized clinical trial of the GLP-1 agonist semaglutide for alcohol use disorder.

JAMA PsychiatryChicago20258 min read

This JAMA Psychiatry randomized trial of once-weekly semaglutide in adults with alcohol use disorder adds to the growing body of evidence that GLP-1 receptor agonists may have effects on craving and consumption beyond their metabolic indications.

The study is small but adds rigor to a question that has been driven largely by anecdote and observational data so far.

Read the full JAMA Psychiatry article for the protocol and outcomes.

Read the original at JAMA Psychiatry

Mental Hum is a reading list, not a publisher. The summary above is our own editorial framing; the reporting and analysis live at the source.

If reading this brought something up for you —

Call or text 988 for the Suicide & Crisis Lifeline. See all crisis resources.